← Open Payments lookup

JOHN HUBBARD: Open Payments

NPI 1881640555 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,654 in 174 payments from 16 companies in 2025. Trend: 2023 $2,474 · 2024 $4,067 · 2025 $4,654

Food & beverage: $4,583Education: $71
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)29$721
ABBVIE INC.20$638
Vanda Pharmaceuticals Inc.21$627
E.R. Squibb & Sons, L.L.C.15$588
Otsuka America Pharmaceutical, Inc.13$412
Neurocrine BioSciences, Inc.25$405
Teva Pharmaceuticals USA, Inc.14$309
Axsome Therapeutics, Inc.7$212
Janssen Pharmaceuticals, Inc5$190
Bausch Health US, LLC7$159

Products named: CAPLYTA, VRAYLAR, COBENFY, FANAPT, INGREZZA, ABILIFY MAINTENA, Auvelity, HETLIOZ.

Industry payments across AL — which companies pay providers there.